martes, 1 de septiembre de 2020

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome | BMC Cancer | Full Text

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome | BMC Cancer | Full Text

Differentiation syndrome (DS) is the main life-threatening adverse event that occurs in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA). Cytokine imbalances have been re...
Authors:Luciana Yamamoto de Almeida, Diego Antonio Pereira-Martins, Ana Sílvia Gouvêa Lima, Márcia Sueli Baggio, Luisa Corrêa de Araujo Koury, Ana Paula Lange, Sarah Cristina Bassi, Priscila Santos Scheucher and Eduardo Magalhães Rego
Citation:BMC Cancer 2020 20:821
Content type:Research article
 
Published on: 

No hay comentarios:

Publicar un comentario